0000008063-26-000021
SEC filingSales grew 8.4% to $862M driven by Aerospace strength, net income turned positive to $29.4M on operating leverage and lower interest.
Astronics Corporation describes itself as a leading provider of advanced technologies to the global aerospace, defense, and electronics industries. The company designs and manufactures high-performance electrical power generation, distribution and motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. Principal operations are in the U.S., Canada, France, and Germany, with engineering offices in Ukraine and India.
The Company operates two reportable segments: Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the global aerospace and defense industry, with sales in 2025 divided 75% to commercial transport, 15% to military aircraft, 9% to general aviation, and 1% to other markets. The Test Systems segment designs, develops, manufactures, and maintains automated test systems for aerospace/defense, communications, and mass transit industries, along with training and simulation devices.
Key product lines include lighting and safety systems, electrical power generation and distribution, seat motion systems, aircraft structures, avionics, systems certification, automated test systems, and training/simulation devices. Acquisitions in 2025 added Envoy Aerospace (FAA ODA services) and Bühler Motor Aviation (seat actuation systems with actuators, electronics, control panels, pneumatic systems, and lighting).
The Aerospace segment generates most sales from contracts or purchase orders on a day-to-day or single-year basis, though some multi-year blanket orders exist. The Test Systems segment pursues large, often multi-year projects. Customers include OEMs (airframe manufacturers), suppliers, aircraft operators (airlines), and the U.S. Department of Defense. A significant customer concentration exists with The Boeing Company, representing 10.4% of 2025 sales, primarily in Aerospace. Government-related markets accounted for about 15% of consolidated sales in 2025.
The company faces considerable competition in its market sectors, primarily on product performance and price. Many competitors are substantially larger with greater resources. Success depends on product innovation, customer support, responsiveness, and cost management. The company continues to invest in technologies and engineering support to remain competitive.
The company's strategy is to increase value by developing technologies and capabilities either internally or through acquisition, and apply them to provide innovative solutions to targeted markets. This is supported by ongoing investment in R&D ($52.1 million in 2024, $53.7 million in 2023) and a focus on product innovation, customer support, and cost management.
As of December 31, 2025, Astronics employed approximately 2,700 full-time employees: 2,100 in the U.S. and 600 outside the U.S. About 150 non-exempt production employees are covered by collective bargaining agreements. The company emphasizes a positive work culture, competitive compensation, and employee development, having earned several 'best employer' awards.
Astronics Corporation reported consolidated sales of $862.1 million for fiscal 2025, an 8.4% increase from $795.4 million in 2024. The growth was primarily driven by the Aerospace segment, which posted a 12.8% sales increase to $797.3 million, more than offsetting a 23.9% decline in Test Systems sales to $64.8 million. Gross profit rose 17.1% to $258.2 million, resulting in a gross margin expansion from 27.7% to 29.9%, supported by higher volumes, favorable product mix, and pricing initiatives. Operating income improved significantly to $76.4 million (8.9% margin) from $26.5 million (3.3% margin) in the prior year, as operating leverage and a $5.6 million decrease in litigation-related legal expenses more than offset $10.4 million in tariff costs and $6.2 million in simplification charges. Net income swung to $29.4 million ($0.81 per diluted share) compared to a net loss of $16.2 million ($0.46 per share), benefitting from a $9.4 million reduction in interest expense and a $2.6 million tax expense vs. $8.3 million in 2024.
The Aerospace segment was the primary growth engine, with sales rising 12.8% to $797.3 million. Commercial Transport sales increased 14.2% to $599.3 million, driven by airline demand for cabin power, lighting, safety, and seat motion systems. Military Aerospace sales surged 32.1% to $116.3 million on pricing and the MV-75 program, while General Aviation declined 6.1% to $69.8 million due to timing of airframe power programs. Segment operating profit rose to $113.2 million (14.2% margin) from $62.4 million (8.8% margin), reflecting leverage on higher volume and favorable mix, partly offset by $6.2 million in simplification costs. Test Systems segment sales fell 23.9% to $64.8 million, driven by lower radio test program sales and an $8.3 million negative revenue impact from revised cost estimates on long-term mass transit contracts. Operating loss improved slightly to $7.8 million from $8.5 million, as $8.8 million in adverse cost revisions were partially offset by restructuring savings. Total segment backlog increased to $674.5 million from $599.2 million, with a book-to-bill ratio of 1.07.
Management highlighted improving commercial transport fundamentals, with expected increases in 737 MAX and A-320 production rates in 2026-2027 and a strengthening aftermarket. Military and Test Systems markets remain dependent on government funding and program wins, with no single program reliance. The company continues to face supply chain pressures, tariff uncertainties (including the IEEPA tariff case remanded in January 2026), and labor market challenges. Strategic priorities include driving organic growth through new aircraft program wins, pursuing acquisitions (two completed in 2025), and optimizing operations through simplification initiatives. Capital allocation focuses on reinvestment in technology and debt reduction, with no dividend planned. Liquidity is sufficient with $18.2 million cash and a new $300 million revolving credit facility, and the company expects cash flow from operations to fund operations and the ongoing Lufthansa litigation payments ($21.6 million paid in 2025).
Cash and equivalents increased to $18.2M from $9.3M year-over-year, though restricted cash fell to zero. Total debt rose significantly to $334.5M from $168.7M, driven by the issuance of $225M in zero-coupon 2031 Convertible Notes and a partial repurchase of the 2030 notes. The new Revolving Credit Facility provides $300M capacity with $212.8M available after $85M drawn. Shareholders' equity decreased to $140.1M from $256.1M largely due to the $120.6M reduction in additional paid-in capital from the note repurchase and capped call transactions.
Total remaining performance obligations (backlog) were $674.5M at year-end, with $533.1M expected to be recognized in 2026. Operating lease commitments total $55.0M over the lease term, with annual payments ranging from $6-8M through 2030 and $18.0M thereafter. The company also has warranty liabilities of $20.7M and legal reserves related to Lufthansa matters totaling $17.6M (non-current) and $1.0M current.
The Board has $41.5M remaining under the share buyback program, but no shares were repurchased in 2025. No cash dividends have been paid in the last three years. Capital expenditures surged to $31.7M (3.7% of sales) from $8.4M in 2024, primarily for facility expansion and deferred maintenance. Debt management was active: $225M in 2031 convertible notes were issued, with $132M of 2030 notes repurchased, resulting in a $32.6M loss on settlement. The ABL facility was replaced with a $300M cash-flow revolver.
Aerospace segment revenue grew 12.8% to $797.3M, with operating income jumping 81.4% to $113.2M (14.2% margin). Growth was led by Commercial Transport (up 14.2% to $599.3M) and Military Aircraft (up 32.1% to $116.3M). Test Systems revenue declined 27.0% to $64.8M, with an operating loss of $7.8M. Geographically, U.S. sales accounted for 71.4% of total revenue, with Europe at 17.8% and Asia at 8.5%. Foreign net assets grew to $67.8M from $41.3M.
Astronics faces significant customer concentration, with Boeing representing approximately 10.4% of 2025 sales. The loss or reduction of this business would materially impact revenue. Additionally, the cyclical nature of aerospace and defense markets exposes the company to downturns from economic conditions, pandemics, or geopolitical events.
The most pressing legal risk is the Lufthansa Technik patent infringement litigation. The UK court awarded about $21.6 million in damages, interest, and costs, which were paid in 2025. An appeal is scheduled for March 2026, and additional amounts could be substantial. The company also faces regulatory risks from government contracting, including audits, compliance with export controls, and potential debarment.
As of December 31, 2025, Astronics had $343 million in total debt, including $225 million in non-interest-bearing convertible notes due 2031. The revolving credit facility imposes financial covenants (e.g., total leverage ratio, interest coverage ratio). Non-compliance could lead to acceleration of debt. The company reported net losses in 2023 and 2024, though net income was achieved in 2025; future profitability is uncertain.
Almost all of Astronics' sales are under fixed-price contracts, exposing the company to cost overruns. Supply chain constraints and tariffs on imported components could increase material costs. The company also relies on subcontractors and faces risks of labor shortages and work stoppages. Cybersecurity threats are a concern, with potential for data breaches impacting operations and government contracts.
The company's growth strategy includes acquisitions, which carry integration risks and potential unanticipated liabilities. Technological change could render products obsolete if innovation lags. Competition from larger, more diversified firms pressures margins.
Net income turned positive at $29.4M in FY2025 versus losses in prior years, significantly boosting CFO. However, CFO of $74.8M included large non-cash adjustments: depreciation/amortization ($21.8M), loss on debt settlement ($32.6M), and simplification charges ($6.2M). Working capital was a net use of cash ($33.4M) as receivables, inventories, and payables all increased, partially offset by tenant improvement refund ($8.1M). CapEx surged to $31.7M (4.2x prior year), signaling heavy investment. Free cash flow (implied CFO minus CapEx) was about $43.1M. Financing activities included $225M convertible debt issuance offset by $285.8M partial repurchase of notes and $26.9M capped call payments. Overall, cash generation improved markedly but remains reliant on non-cash gains and faces elevated capex intensity.